Profound Medical Cash Flow Statement (2023-2025) | PROF

Cash Flow Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income 6.64M7.29M5.53M-48.62M-6.58M-6.92M-9.37M-5.56M-10.72M-15.71M-7.98M
Depreciation and Depletion 0.18M0.17M0.18M0.20M0.20M0.18M0.16M0.16M0.12M0.10M0.09M
Share-based Compensation 0.77M0.77M0.60M0.44M0.99M1.45M1.67M
Gains from Sales and Divestitures 0.16M0.23M0.01M0.01M0.15M
Gains from Investment Securities -0.12M0.35M0.01M0.16M0.04M2.29M0.01M2.15M2.15M
Non-cash Items 1.22M0.43M1.17M1.19M1.17M
Cash from Operations 5.82M5.12M-26.22M-7.33M-4.53M-6.22M-6.83M-5.88M-8.28M-13.74M-9.61M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.05M0.05M0.06M0.04M0.05M0.05M0.05M0.08M0.05M0.04M0.05M
Amortization 1.86M2.02M1.73M2.02M2.23M2.83M
Depreciation & Amortization (CF) 0.18M0.17M0.18M0.20M0.20M0.18M0.16M0.16M0.12M0.10M0.09M
Change in Working Capital
Change in Receivables 6,995.00M6.59M6.62M1.11M6.51M7.16M7.03M0.59M-1.09M-1.36M3.36M
Change in Inventory 8,125.00M8.06M7.42M-0.30M6.98M6.73M6.43M-0.48M0.98M1.74M-0.13M
Change in Account Payables 0.02M2.42M2.02M1.19M2.88M2.67M3.40M
Change in Accured Expenses -0.57M0.06M0.68M0.65M0.30M0.24M-0.21M
Change in Taxes 0.05M0.04M0.34M-0.34M0.05M0.02M-0.00M
Other Working Capital Changes -0.37M0.41M-0.11M0.12M0.05M-1.01M0.25M0.07M-0.22M
Financing Activities
Other financing activities 20.81M21.57M21.93M20.92M3.04M-0.09M1.04M
Cash from Financing Activities 2.14M-0.19M-0.20M20.46M-0.60M-0.59M35.44M-0.29M
Additional items
Exchange Rate Effect 0.15M4.12M-3.73M0.12M-0.96M0.83M0.46M-1.77M0.09M2.51M-0.76M
Change in Cash -3.68M-5.12M-4.53M-7.53M15.93M-6.82M-7.42M29.56M-8.57M-13.74M-9.61M
Free Cash Flow 5.82M5.12M-26.22M-7.33M-4.53M-6.22M-6.83M-5.88M-8.28M-13.74M-9.61M
Net Cash Flow 7.97M5.12M-26.41M-7.53M15.93M-6.82M-7.42M29.56M-8.57M-13.74M-9.61M